IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Monday for AtriCure
(Updated on Apr 15, 2024)

Sell candidate since Mar 12, 2024 Loss -34.48% PDF

The AtriCure stock price fell by -4.94% on the last day (Monday, 15th Apr 2024) from $24.09 to $22.90. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 9.00% from a day low at $22.49 to a day high of $24.52. The price has fallen in 7 of the last 10 days and is down by -21.28% for this period. Volume has increased on the last day by 746 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $29.72 million.

Given the current short-term trend, the stock is expected to fall -18.20% during the next 3 months and, with a 90% probability hold a price between $18.73 and $28.08 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

ATRC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The AtriCure stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.52 and $31.06. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -39.39%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for AtriCure stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.03 between high and low, or 9.00%. For the last week, the stock has had daily average volatility of 5.68%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRC) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect AtriCure to open at $23.30, and during the day (based on 14 day Average True Range), to move between $21.51 and $24.29, which gives a possible trading interval of +/-$1.39 (+/-6.09%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 12.17% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $26.48, some $3.58 (15.63%) from the current price of $22.90, our system finds the risk reward not very attractive.

Is AtriCure stock A Buy?

AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.481 Strong Sell Candidate Unchanged

Predicted Opening Price for AtriCure of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$23.30 ( 1.75%) $22.90

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.33 10.60 %
R2 24.55 7.22 %
R1 24.08 5.13 %
Current price: 22.90
Support S1 22.53 -1.62 %
S2 22.05 -3.71 %
S3 21.28 -7.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 28.47 24.32 %
R2 27.61 20.57 %
R1 26.48 15.63 %
Current price 22.90
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the 2024-04-15, the price of an AtriCure (ATRC) share was $22.90.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $59.61 and the 52-week low is $22.49.

What is the market capitalization of AtriCure Stock?
As of the 2024-04-15, the market capitalization of AtriCure is 1.108B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is May 01, 2024.
Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT